Enveric Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Enveric Biosciences, Inc. (ENVB) on April 14, 2025. The filing discloses a change in the Company's independent registered public accounting firm. The Company is incorporated in Delaware and its principal executive offices are located in Naples, Florida.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the current period. However, it references the Company's Annual Report on Form 10-K for the year ended December 31, 2024, which included an explanatory paragraph from the auditor relating to substantial doubt about the Company's ability to continue as a going concern.
Material Changes
- Change in Auditor: The Company dismissed Marcum LLP as its independent registered public accounting firm effective April 14, 2025. CBIZ CPAs P.C. was engaged to serve as the new independent registered public accounting firm for the year ending December 31, 2025, effective immediately.
- Reason for Change: The change occurred because CBIZ CPAs acquired the attest business of Marcum LLP effective November 1, 2024. Marcum continued to serve the Company until the date of this filing.
- Internal Control Weaknesses: Management concluded that material weaknesses in internal controls over financial reporting existed for the fiscal years ended December 31, 2023, and December 31, 2024. These weaknesses were attributed to insufficient segregation of duties, lack of oversight, limited personnel and resources, and failures in documenting and testing controls over risk assessment and information technology.
Guidance, Risks, and Contingencies
The filing does not contain forward-looking guidance or specific management commentary regarding future financial performance. The primary risk disclosed is the material weakness in internal controls over financial reporting, which impacts the reliability of financial statements. Additionally, the prior year's audit report highlighted substantial doubt regarding the Company's ability to continue as a going concern.
Investor Verification Checklist
- Verify the status of the "substantial doubt about going concern" noted in the 2024 audit report.
- Review the Company's plan to remediate the disclosed material weaknesses in internal controls over financial reporting.
- Confirm the transition timeline and scope of work between Marcum LLP and CBIZ CPAs P.C.
- Examine the Company's liquidity position and capital resources given the going concern warning.